CiteFacts · FDA Drug Shortages · FDA source
FDA shortage status: Quinapril Hydrochloride Tablet
FDA source answer
FDA currently lists this ingredient in shortage.
FDA source statuses: Current. First FDA posting: 2023-01-19. Latest FDA row update: 2026-10-02.
FDA lists 16 package records, with companies: Aurobindo Pharma Limited, Aurobindo Pharma USA, Chartwell Molecular Holdings LLC, Chartwell RX, LLC, Lupin Pharmaceuticals, Inc., Solco Healthcare US, LLC. Package NDCs: 43547-410-09, 43547-411-09, 43547-412-09, 43547-413-09, 62135-484-60, 62135-485-90, 62135-486-90, 62135-487-90, 65862-617-90, 65862-618-90, 65862-620-90, 68180-554-09, 68180-556-09, 68180-557-09, 68180-558-09.
FDA shortage reason: Discontinuation of the manufacture of the drug; Requirements related to complying with good manufacturing practices; Shortage of an active ingredient
This is nationwide FDA status, not local pharmacy inventory. CiteFacts does not provide medical, treatment, substitution, or dosing advice.
FDA package and manufacturer records
| Company | Package NDC | Presentation | FDA availability field | FDA update |
|---|---|---|---|---|
| Aurobindo Pharma USA | 65862-618-90 | Quinapril Hydrochloride, Tablet, 10 mg (NDC 65862-618-90) | Unavailable | 2026-10-02 |
| Aurobindo Pharma USA | 65862-618-90 | Quinapril Hydrochloride, Tablet, 10 mg (NDC 65862-618-90) | Unavailable | 2026-10-02 |
| Aurobindo Pharma USA | 65862-620-90 | Quinapril Hydrochloride, Tablet, 40 mg (NDC 65862-620-90) | Unavailable | 2026-10-02 |
| Aurobindo Pharma USA | 65862-617-90 | Quinapril Hydrochloride, Tablet, 5 mg (NDC 65862-617-90) | Unavailable | 2026-10-02 |
| Chartwell Molecular Holdings LLC | 62135-485-90 | Quinapril Hydrochloride, Tablet, 10 mg (NDC 62135-485-90) | Available | 2026-10-02 |
| Chartwell Molecular Holdings LLC | 62135-486-90 | Quinapril Hydrochloride, Tablet, 20 mg (NDC 62135-486-90) | Available | 2026-10-02 |
| Chartwell Molecular Holdings LLC | 62135-487-90 | Quinapril Hydrochloride, Tablet, 40 mg (NDC 62135-487-90) | Available | 2026-10-02 |
| Chartwell Molecular Holdings LLC | 62135-484-60 | Quinapril Hydrochloride, Tablet, 5 mg (NDC 62135-484-60) | Available | 2026-10-02 |
| Lupin Pharmaceuticals, Inc. | 68180-557-09 | Quinapril Hydrochloride, Tablet, 10 mg (NDC 68180-557-09) | Unavailable | 2026-09-01 |
| Lupin Pharmaceuticals, Inc. | 68180-558-09 | Quinapril Hydrochloride, Tablet, 20 mg (NDC 68180-558-09) | Unavailable | 2026-09-01 |
| Lupin Pharmaceuticals, Inc. | 68180-554-09 | Quinapril Hydrochloride, Tablet, 40 mg (NDC 68180-554-09) | Unavailable | 2026-09-01 |
| Lupin Pharmaceuticals, Inc. | 68180-556-09 | Quinapril Hydrochloride, Tablet, 5 mg (NDC 68180-556-09) | Unavailable | 2026-09-01 |
| Solco Healthcare US, LLC | 43547-411-09 | Quinapril Hydrochloride, Tablet, 10 mg (NDC 43547-411-09) | Unavailable | 2026-06-29 |
| Solco Healthcare US, LLC | 43547-412-09 | Quinapril Hydrochloride, Tablet, 20 mg (NDC 43547-412-09) | Unavailable | 2026-06-29 |
| Solco Healthcare US, LLC | 43547-413-09 | Quinapril Hydrochloride, Tablet, 40 mg (NDC 43547-413-09) | Unavailable | 2026-06-29 |
| Solco Healthcare US, LLC | 43547-410-09 | Quinapril Hydrochloride, Tablet, 5 mg (NDC 43547-410-09) | Unavailable | 2026-06-29 |
Source facts
Grouped generic ingredient: Quinapril Hydrochloride Tablet · 16 package records
Therapeutic categories: Cardiovascular
Dosage forms: Tablet
Routes: ORAL
Open FDA source data · JSON · Markdown
FDA is authoritative. Source retrieved 2026-10-06T18:55:41+00:00. Derived grouping is documented in this record's derivations.